Cargando…
Angiotensin receptor autoantibodies as exposures that modify disease progression: Cross sectional, longitudinal and in vitro studies of prostate cancer
Circulating angiotensin type I receptor (AT1R) agonistic autoantibodies (AT1RaAbs) that bind and chronically activate the receptor have been associated with a number of diseases suggesting that while the autoantibodies are not necessarily causative they may promote disease progression. The prostate...
Autores principales: | Jain, Alka, Shah, Haikoo, Simonsick, Eleanor M., Metter, E. Jeffrey, Mangold, Leslie, Humphreys, Elizabeth, Partin, Alan, Fedarko, Neal S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6953913/ https://www.ncbi.nlm.nih.gov/pubmed/31930191 http://dx.doi.org/10.1016/j.jtauto.2019.100008 |
Ejemplares similares
-
Association of Angiotensin Receptor Autoantibodies With Cardiovascular Abnormalities in Preeclampsia
por: Minhas, Anum S., et al.
Publicado: (2021) -
NATURALLY OCCURRING VARIABILITY IN FINANCIAL STRESS AND INFLAMMATORY BIOMARKERS AMONG OLDER ADULTS
por: Samuel, Laura, et al.
Publicado: (2019) -
Urinary marker panels for aggressive prostate cancer detection
por: Lih, Tung-Shing Mamie, et al.
Publicado: (2022) -
Serum markers of apoptosis decrease with age and cancer stage
por: Kavathia, Nilay, et al.
Publicado: (2009) -
Promoter methylation of MCAM, ERα and ERβ in serum of early stage prostate cancer patients
por: Brait, Mariana, et al.
Publicado: (2017)